COMPASS Pathways (CMPS)
(Real Time Quote from BATS)
$6.75 USD
-0.19 (-2.74%)
Updated Jun 14, 2024 09:48 AM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Brokerage Reports
0 items in cart
COMPASS Pathways PLC Sponsored ADR [CMPS]
Reports for Purchase
Showing records 1 - 20 ( 83 total )
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Key Takeaway From Biotech Breakthroughs Oncology Event: The Rise of PRAME-Targeted Therapies
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Key Takeaway From Biotech Breakthroughs Psychiatry Event
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
4Q23 Results; COMP360 Phase 3 Data Slightly Delayed to 4Q24; COMP360 Phase 2 PTSD Data Expected Spring 2024; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
2024 Top Picks: Seeing Important Turnaround Year While Watching the Macro
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
2024 Top Picks: Seeing Important Turnaround Year While Watching the Macro
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Management Breakfast Elucidates Blockbuster Potential of COMP360 in Psychiatry; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
COMP360 Clears Initial Safety Hurdle in Phase 2 PTSD Program; Hosting Management Breakfast on January 10; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Optimized Entry and Exit Levels for CMPS 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
3Q23 Results; COMP360 on Track for Phase 2 PTSD Data in 4Q23 and Phase 3 Depression Data in Summer 2024; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Key Takeaways From 25th Annual Global Conference: Multiple Underappreciated Programs to Shine in 2H23 and 2024
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
2Q23 Results; COMP360 Phase 3 Treatment-Resistant Depression Trials on Track; PTSD Data Expected 4Q23; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Takeaways From Recent Conferences: Nearing a Psychedelic Breakout With Plethora of Catalysts; LP352 to Shine in Epilepsy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Category III CPT Code a "Game Changer for the Field of Psychiatry" and Should Accelerate Reimbursement for COMP360
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
COMP360 Pivotal Program Progressing; Reimbursement Codes Advancing; No Surprises in FDA Psychedelics Guidance; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
COMP360 Intellectual Property Appears Robust as Key Patents Upheld by USPTO; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
1Q23 Results; Phase 3 COMP360 TRD Data on Track for Summer 2024; PTSD Readout Expected 4Q23; Tweaks Anorexia Program
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
4Q22 Results; Streamlines and Accelerates COMP360 Phase 3 Program; Achieves Reimbursement Win; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Bullish Start to the Year for Psychedelic Drug Development Companies Ahead of a Plethora of Potential Positive Events
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: COMPASS Pathways PLC Sponsored ADR
Industry: Medical Services
Several Studies Presented Including Data Pointing to the Potential for Psychedelics in Bipolar Depression; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P